Tag Archives: Depression

Magnetic Seizure Therapy – How Unattractive!

Fry your brain with magnetic seizure therapy! Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , | Leave a comment

How psychiatry Usurps Climate Change Planning

The psycho-pharmaceutical industry has jumped full-time onto the climate change bandwagon. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Leave a comment

Scientists Gave Ketamine to Sheep and were Baaaffled by the Result

The use of ketamine to treat so-called depression is unethical. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , | Leave a comment

Psychiatrists Anxious to Treat All Child-bearing Women for Post-Partum Depression

The Drugging of ‘Post Partum Depression’ Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , | Leave a comment

Set It and Forget It Birth Control

Need we actually say that a depressive side effect of an IUD is not a “mental illness” requiring an antidepressant? Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , | Leave a comment

Knock Yourself Out with Spravato (Esketamine)

Any form of ketamine used to treat so-called depression is unethical and harmful. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Leave a comment

Depression and The Marketing of Madness

How did psychotropic drugs become the go-to treatment? Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , | Leave a comment

Orilissa May Cause Suicidal Ideation

Orilissa May Cause Suicidal Ideation Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , | Leave a comment

1 in 4 Elderly Americans Hooked on Xanax

This abusive assault on the elderly is the result of psychiatry maneuvering itself into an authoritative position over aged care. Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , | Leave a comment

Rexulti Fails to Get Results

REXULTI (generic brexpiprazole) is a prescription psychiatric drug from Otsuka Pharmaceutical Company and Lundbeck pharmaceutical company. Although it failed Phase II clinical trials for attention-deficit hyperactivity disorder (ADHD), it was approved by the U.S. Food and Drug Administration (FDA) in … Continue reading

Posted in Big Muddy River Newsletter | Tagged , , , , , , , , | Leave a comment